Cell Therapy

Cancer targeting by TCR gene-engineered T cells directed against Kita-Kyushu Lung Cancer Antigen-1
Bridget Marcinkowski, Sanja Stevanović, Sarah R. Helman, Scott M. Norberg, Carylinda Serna, Benjamin Jin, Nikolaos Gkitsas, Tejas Kadakia, Andrew Warner, Jeremy L. Davis, Lisa Rooper, Christian S. Hinrichs

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 229; DOI: 10.1186/s40425-019-0678-x
Challenges and next steps in the advancement of immunotherapy: summary of the 2018 and 2020 National Cancer Institute workshops on cell-based immunotherapy for solid tumors
Laura K Fogli, Rosemarie Aurigemma, Connie L Sommers, Anju Singh, Kasia Bourcier, Marc S Ernstoff

Journal for ImmunoTherapy of Cancer Jul 2021, 9 (7) e003048; DOI: 10.1136/jitc-2021-003048
A monocyte and interferon based cell therapy for the treatment of ovarian cancer
Daniel Green, Chase Johnson, Kathryn Zoon

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P222; DOI: 10.1186/2051-1426-3-S2-P222
Improving adoptive T cell therapy with adenoviruse armed with TNF-α and IL-2
Riikka Havunen, Mikko Siurala, Suvi Parviainen, Simona Bramante, Dipongor Saha, Siri Tähtinen, Markus Vähä-Koskela, Michael Behr, Dirk Nettelbeck, Anja Ehrhardt, Akseli Hemminki

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P41; DOI: 10.1186/2051-1426-3-S2-P41
Identification of tumor-specific T cell receptors from primary tumor-infiltrating lymphocytes
Hiroyuki Kishi, Hiroshi Hamana, Kiyomi Shitaoka, Atsushi Muraguchi

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P74; DOI: 10.1186/2051-1426-3-S2-P74
Targeting FRβ+ tumor associated macrophages with car T cells in ovarian cancer
Rachel C Lynn, Takami Matsuyama, Daniel J Powell

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P32; DOI: 10.1186/2051-1426-3-S2-P32
Interleukin-15 potentiates human natural killer cells to resist tumor-induced suppression through mTOR-regulated metabolic control
Andreas Lundqvist, Yumeng Mao, Xiaonan Zhang, Erik Wennerberg, Vincent Van Hoef, Ola Larsson, Stig Linder, Rolf Kiessling

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P232; DOI: 10.1186/2051-1426-3-S2-P232
Feasibility and safety of cCD20 RNA CAR-bearing T cell therapy for the treatment of canine B cell malignancies
Jenessa B Smith, M Kazim Panjwani, Keith Schutsky, Josephine Gnanandarajah, Sondra Calhoun, Laurence Cooper, Nicola Mason, Daniel J Powell

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P123; DOI: 10.1186/2051-1426-3-S2-P123
Cryopreserved leukopaks maintain cell viability and functionality: a solution for cell therapy logistics
George Eastwood, Wenshi Wang, Tia Hexom, Laura-Marie Nucho

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P383; DOI: 10.1186/2051-1426-3-S2-P383
Clinical scale labeling of T cell immunotherapy for MRI cell tracking
Brooke M Helfer, William Shingleton, Shannon Eaker, Charles O'Hanlon, Eric Ahrens

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P389; DOI: 10.1186/2051-1426-3-S2-P389

Main menu

Cell Therapy

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Cell Therapy

Pages